"World's Most Complete Market Research Reports Repository"

Global Psoriasis Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 675279
  • |
  • Publishe Date : 6-Nov-18
  • |
  • No of Pages: 122
  • |
  • Publisher : Global Info Research



Scope of the Report:

Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone to this condition.

The global Psoriasis Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psoriasis Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Psoriasis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Psoriasis Drugs market by product type and applications/end industries.



Market Segment by Companies, this report covers

AbbVie

Amgen

Johnson & Johnson

Novartis

Eli Lilly & Company

AstraZeneca

Celgene Corporation

UCB

Merck



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Tumor Necrosis Factor Inhibitor

Interleukin Inhibitors

Others



Market Segment by Applications, can be divided into

Topicals

Systemic

Biologics

Table of Contents



1 Psoriasis Drugs Market Overview

1.1 Product Overview and Scope of Psoriasis Drugs

1.2 Classification of Psoriasis Drugs by Types

1.2.1 Global Psoriasis Drugs Revenue Comparison by Types (2017-2023)

1.2.2 Global Psoriasis Drugs Revenue Market Share by Types in 2017

1.2.3 Tumor Necrosis Factor Inhibitor

1.2.4 Interleukin Inhibitors

1.2.5 Others

1.3 Global Psoriasis Drugs Market by Application

1.3.1 Global Psoriasis Drugs Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Topicals

1.3.3 Systemic

1.3.4 Biologics

1.4 Global Psoriasis Drugs Market by Regions

1.4.1 Global Psoriasis Drugs Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Psoriasis Drugs Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Psoriasis Drugs Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psoriasis Drugs Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Psoriasis Drugs Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psoriasis Drugs Status and Prospect (2013-2023)

1.5 Global Market Size of Psoriasis Drugs (2013-2023)

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Psoriasis Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.2 Amgen

2.2.1 Business Overview

2.2.2 Psoriasis Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Amgen Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.3 Johnson & Johnson

2.3.1 Business Overview

2.3.2 Psoriasis Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Johnson & Johnson Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Psoriasis Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eli Lilly & Company

2.5.1 Business Overview

2.5.2 Psoriasis Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eli Lilly & Company Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.6 AstraZeneca

2.6.1 Business Overview

2.6.2 Psoriasis Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 AstraZeneca Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.7 Celgene Corporation

2.7.1 Business Overview

2.7.2 Psoriasis Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Celgene Corporation Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.8 UCB

2.8.1 Business Overview

2.8.2 Psoriasis Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 UCB Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

2.9 Merck

2.9.1 Business Overview

2.9.2 Psoriasis Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Merck Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 Global Psoriasis Drugs Market Competition, by Players

3.1 Global Psoriasis Drugs Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Psoriasis Drugs Players Market Share

3.2.2 Top 10 Psoriasis Drugs Players Market Share

3.3 Market Competition Trend

4 Global Psoriasis Drugs Market Size by Regions

4.1 Global Psoriasis Drugs Revenue and Market Share by Regions

4.2 North America Psoriasis Drugs Revenue and Growth Rate (2013-2018)

4.3 Europe Psoriasis Drugs Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Psoriasis Drugs Revenue and Growth Rate (2013-2018)

4.5 South America Psoriasis Drugs Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)

5 North America Psoriasis Drugs Revenue by Countries

5.1 North America Psoriasis Drugs Revenue by Countries (2013-2018)

5.2 USA Psoriasis Drugs Revenue and Growth Rate (2013-2018)

5.3 Canada Psoriasis Drugs Revenue and Growth Rate (2013-2018)

5.4 Mexico Psoriasis Drugs Revenue and Growth Rate (2013-2018)

6 Europe Psoriasis Drugs Revenue by Countries

6.1 Europe Psoriasis Drugs Revenue by Countries (2013-2018)

6.2 Germany Psoriasis Drugs Revenue and Growth Rate (2013-2018)

6.3 UK Psoriasis Drugs Revenue and Growth Rate (2013-2018)

6.4 France Psoriasis Drugs Revenue and Growth Rate (2013-2018)

6.5 Russia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

6.6 Italy Psoriasis Drugs Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Psoriasis Drugs Revenue by Countries

7.1 Asia-Pacific Psoriasis Drugs Revenue by Countries (2013-2018)

7.2 China Psoriasis Drugs Revenue and Growth Rate (2013-2018)

7.3 Japan Psoriasis Drugs Revenue and Growth Rate (2013-2018)

7.4 Korea Psoriasis Drugs Revenue and Growth Rate (2013-2018)

7.5 India Psoriasis Drugs Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

8 South America Psoriasis Drugs Revenue by Countries

8.1 South America Psoriasis Drugs Revenue by Countries (2013-2018)

8.2 Brazil Psoriasis Drugs Revenue and Growth Rate (2013-2018)

8.3 Argentina Psoriasis Drugs Revenue and Growth Rate (2013-2018)

8.4 Colombia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Psoriasis Drugs by Countries

9.1 Middle East and Africa Psoriasis Drugs Revenue by Countries (2013-2018)

9.2 Saudi Arabia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

9.3 UAE Psoriasis Drugs Revenue and Growth Rate (2013-2018)

9.4 Egypt Psoriasis Drugs Revenue and Growth Rate (2013-2018)

9.5 Nigeria Psoriasis Drugs Revenue and Growth Rate (2013-2018)

9.6 South Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)

10 Global Psoriasis Drugs Market Segment by Type

10.1 Global Psoriasis Drugs Revenue and Market Share by Type (2013-2018)

10.2 Global Psoriasis Drugs Market Forecast by Type (2018-2023)

10.3 Tumor Necrosis Factor Inhibitor Revenue Growth Rate (2013-2023)

10.4 Interleukin Inhibitors Revenue Growth Rate (2013-2023)

10.5 Others Revenue Growth Rate (2013-2023)

11 Global Psoriasis Drugs Market Segment by Application

11.1 Global Psoriasis Drugs Revenue Market Share by Application (2013-2018)

11.2 Psoriasis Drugs Market Forecast by Application (2018-2023)

11.3 Topicals Revenue Growth (2013-2018)

11.4 Systemic Revenue Growth (2013-2018)

11.5 Biologics Revenue Growth (2013-2018)

12 Global Psoriasis Drugs Market Size Forecast (2018-2023)

12.1 Global Psoriasis Drugs Market Size Forecast (2018-2023)

12.2 Global Psoriasis Drugs Market Forecast by Regions (2018-2023)

12.3 North America Psoriasis Drugs Revenue Market Forecast (2018-2023)

12.4 Europe Psoriasis Drugs Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Psoriasis Drugs Revenue Market Forecast (2018-2023)

12.6 South America Psoriasis Drugs Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Psoriasis Drugs Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Psoriasis Drugs Picture

Table Product Specifications of Psoriasis Drugs

Table Global Psoriasis Drugs and Revenue (Million USD) Market Split by Product Type

Figure Global Psoriasis Drugs Revenue Market Share by Types in 2017

Figure Tumor Necrosis Factor Inhibitor Picture

Figure Interleukin Inhibitors Picture

Figure Others Picture

Table Global Psoriasis Drugs Revenue (Million USD) by Application (2013-2023)

Figure Psoriasis Drugs Revenue Market Share by Applications in 2017

Figure Topicals Picture

Figure Systemic Picture

Figure Biologics Picture

Table Global Market Psoriasis Drugs Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Psoriasis Drugs Revenue (Million USD) and Growth Rate (2013-2023)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Psoriasis Drugs Type and Applications

Table AbbVie Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Psoriasis Drugs Type and Applications

Table Amgen Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Psoriasis Drugs Type and Applications

Table Johnson & Johnson Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Psoriasis Drugs Type and Applications

Table Novartis Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly & Company Basic Information, Manufacturing Base and Competitors

Table Eli Lilly & Company Psoriasis Drugs Type and Applications

Table Eli Lilly & Company Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Psoriasis Drugs Type and Applications

Table AstraZeneca Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Corporation Basic Information, Manufacturing Base and Competitors

Table Celgene Corporation Psoriasis Drugs Type and Applications

Table Celgene Corporation Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table UCB Basic Information, Manufacturing Base and Competitors

Table UCB Psoriasis Drugs Type and Applications

Table UCB Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Psoriasis Drugs Type and Applications

Table Merck Psoriasis Drugs Revenue, Gross Margin and Market Share (2016-2017)

Table Global Psoriasis Drugs Revenue (Million USD) by Players (2013-2018)

Table Global Psoriasis Drugs Revenue Share by Players (2013-2018)

Figure Global Psoriasis Drugs Revenue Share by Players in 2016

Figure Global Psoriasis Drugs Revenue Share by Players in 2017

Figure Global Top 5 Players Psoriasis Drugs Revenue Market Share in 2017

Figure Global Top 10 Players Psoriasis Drugs Revenue Market Share in 2017

Figure Global Psoriasis Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Psoriasis Drugs Revenue (Million USD) by Regions (2013-2018)

Table Global Psoriasis Drugs Revenue Market Share by Regions (2013-2018)

Figure Global Psoriasis Drugs Revenue Market Share by Regions (2013-2018)

Figure Global Psoriasis Drugs Revenue Market Share by Regions in 2017

Figure North America Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Europe Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure South America Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table North America Psoriasis Drugs Revenue by Countries (2013-2018)

Table North America Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure USA Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Canada Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Mexico Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Europe Psoriasis Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Europe Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure Germany Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure UK Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure France Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Russia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Italy Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Psoriasis Drugs Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure China Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Japan Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Korea Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure India Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table South America Psoriasis Drugs Revenue by Countries (2013-2018)

Table South America Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure Brazil Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Argentina Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Colombia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Psoriasis Drugs Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Psoriasis Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure UAE Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Egypt Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure Nigeria Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Figure South Africa Psoriasis Drugs Revenue and Growth Rate (2013-2018)

Table Global Psoriasis Drugs Revenue (Million USD) by Type (2013-2018)

Table Global Psoriasis Drugs Revenue Share by Type (2013-2018)

Figure Global Psoriasis Drugs Revenue Share by Type (2013-2018)

Figure Global Psoriasis Drugs Revenue Share by Type in 2017

Table Global Psoriasis Drugs Revenue Forecast by Type (2018-2023)

Figure Global Psoriasis Drugs Market Share Forecast by Type (2018-2023)

Figure Global Tumor Necrosis Factor Inhibitor Revenue Growth Rate (2013-2018)

Figure Global Interleukin Inhibitors Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Table Global Psoriasis Drugs Revenue by Application (2013-2018)

Table Global Psoriasis Drugs Revenue Share by Application (2013-2018)

Figure Global Psoriasis Drugs Revenue Share by Application (2013-2018)

Figure Global Psoriasis Drugs Revenue Share by Application in 2017

Table Global Psoriasis Drugs Revenue Forecast by Application (2018-2023)

Figure Global Psoriasis Drugs Market Share Forecast by Application (2018-2023)

Figure Global Topicals Revenue Growth Rate (2013-2018)

Figure Global Systemic Revenue Growth Rate (2013-2018)

Figure Global Biologics Revenue Growth Rate (2013-2018)

Figure Global Psoriasis Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Psoriasis Drugs Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Psoriasis Drugs Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Psoriasis Drugs Revenue Market Forecast (2018-2023)

Figure Europe Psoriasis Drugs Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Psoriasis Drugs Revenue Market Forecast (2018-2023)

Figure South America Psoriasis Drugs Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Psoriasis Drugs Revenue Market Forecast (2018-2023)

Choose License Type